REBECCA CASTILO: Open Payments
NPI 1083227128 · BARTLETT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,507 in 164 payments from 23 companies in 2025. Trend: 2023 $3,273 · 2024 $2,982 · 2025 $3,507
Food & beverage: $3,488Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $742 |
| GENZYME CORPORATION | 10 | $433 |
| Madrigal Pharmaceuticals | 8 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $261 |
| PFIZER INC. | 17 | $238 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $207 |
| Janssen Biotech, Inc. | 9 | $181 |
| Gilead Sciences, Inc. | 9 | $176 |
| Phathom Pharmaceuticals, Inc. | 5 | $171 |
| Ardelyx, Inc. | 10 | $156 |
Products named: DUPIXENT, LINZESS, RINVOQ, REZDIFFRA, ENTYVIO, XIFAXAN, TREMFYA, VELSIPITY.
Industry payments across TN — which companies pay providers there.
